Long-Term, Site-Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72-Week Real-World Study.

Shiba M, Hagino T, Uchiyama A, Saeki H, Fujimoto E, Motegi SI, Kanda N

Open source

DOI
10.1111/1346-8138.70138
Published
2026 Mar
Container
The Journal of dermatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1346-8138.70138,
  title = {Long-Term, Site-Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72-Week Real-World Study.},
  author = {Shiba M and Hagino T and Uchiyama A and Saeki H and Fujimoto E and Motegi SI and Kanda N},
  year = {2026},
  journal = {The Journal of dermatology},
  doi = {10.1111/1346-8138.70138},
  url = {https://doi.org/10.1111/1346-8138.70138}
}

RIS

TY  - JOUR
TI  - Long-Term, Site-Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72-Week Real-World Study.
AU  - Shiba M
AU  - Hagino T
AU  - Uchiyama A
AU  - Saeki H
AU  - Fujimoto E
AU  - Motegi SI
AU  - Kanda N
PY  - 2026
JO  - The Journal of dermatology
DO  - 10.1111/1346-8138.70138
UR  - https://doi.org/10.1111/1346-8138.70138
ER  - 

APA

M, S., T, H., A, U., H, S., E, F., SI, M., & N, K. (2026). Long-Term, Site-Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72-Week Real-World Study.. The Journal of dermatology. https://doi.org/10.1111/1346-8138.70138

Source records